Hello guys,
i don't know if this was already posted here:
In October 2023, India’s counterpart to the US Food and Drug Administration, the Central Drugs Standard Control Organization, made NexCAR19 India’s first approved CAR-T cell therapy. The approval was based on the results of two small clinical trials conducted in IndiaExit Disclaimer in 64 people with advanced lymphoma or leukemia. According to trial results presented in December 2023 at the American Society of Hematology meeting, 67% of patients (36 out of 53) in the two trials had a notable decrease in the extent of their cancer (objective response), with the cancer disappearing altogether in about half (complete response).
https://www.cancer.gov/news-events/cancer-currents-blog/2024/nexcar19-car-t-cell-therapy-india-nci-collaboration
Media Thread, page-11748
-
- There are more pages in this discussion • 3,451 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.1¢ |
Change
-0.001(1.92%) |
Mkt cap ! $378.4M | |||
| Open | High | Low | Value | Volume |
| 5.2¢ | 5.3¢ | 5.1¢ | $326.6K | 6.326M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 29 | 2772219 | 5.1¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.2¢ | 816049 | 28 |
View Market Depth
| Last trade - 11.07am 23/08/2024 (20 minute delay) ? |
| IMU (ASX) Chart |